As the desire for a shortened design/make/test/learn cycle increases in early drug discovery, the pressure to rapidly deliver drug metabolism pharmacokinetic data continues to rise. From a bioanalytic
Raw data describing pre-clinical Mus musculus studies compliance with the Pre-clinical Metabolomics Standards Initiative (MSI) reporting standards. If metadata is reported in accordance with the MSI g
Mucopolysaccharidosis type IIID (MPS IIID; Sanfilippo D) is caused by biallelic pathogenic variants in N-acetylglucosamine-6-sulfatase (GNS), which participates in catabolism of heparan sulfate (HS) g
